Liquid Calcitriol Dosing for a 10-Month-Old Infant (≈9 kg)
For a 10-month-old infant weighing approximately 9 kg with hypoparathyroidism, start liquid calcitriol at 0.18–0.9 mcg/day (0.02–0.1 mcg/kg/day) divided into 3 doses daily, combined with calcium carbonate 360–540 mg/day (40–60 mg/kg/day of elemental calcium) also divided 3 times daily. 1
Age-Specific Dosing Framework
For children under 4 years of age:
- Liquid calcitriol is dosed at 0.02–0.1 mcg/kg/day divided 3 times daily 1
- For a 9 kg infant, this translates to approximately 0.18–0.9 mcg total daily dose
- Supplemental calcium carbonate should be given at 40–60 mg/kg/day (elemental calcium), divided 3 times daily 1
- For a 9 kg infant, calcium dosing would be 360–540 mg/day of elemental calcium
Practical Dosing Strategy
Start conservatively and titrate upward:
- Begin at the lower end of the dosing range (0.02 mcg/kg/day = 0.18 mcg/day total) 1
- Divide the total daily dose into 3 administrations to maintain stable serum calcium levels 1
- The liquid formulation is essential for accurate dosing in infants, as capsule forms cannot be precisely divided 1
For predialysis patients under 3 years (if applicable):
- The FDA label specifies an initial dose of 10–15 ng/kg/day (0.01–0.015 mcg/kg/day) for predialysis CKD patients 2
- This would be 90–135 ng/day (0.09–0.135 mcg/day) for a 9 kg infant
- However, hypoparathyroidism typically requires higher doses than predialysis CKD 1, 2
Critical Monitoring Requirements
Biochemical surveillance must be intensive during dose titration:
- Check serum calcium (albumin-corrected) at least twice weekly during the initial titration period 1, 2
- After dose changes, recheck calcium within 4–7 days 1
- Once stable, monitor calcium monthly 2
- Also monitor serum phosphorus, magnesium, 25(OH)D, and spot urine calcium/creatinine ratio 1
Target serum calcium in the low-normal to mid-normal range to avoid both hypocalcemia complications and hypercalcemia/nephrocalcinosis 1
Dose Adjustment Algorithm
If hypercalcemia develops (serum calcium >9.5 mg/dL or 2.37 mmol/L):
- Immediately discontinue calcitriol until normocalcemia returns 3, 2
- Resume at 50% of the previous dose or switch to alternate-day dosing 3
- Consider reducing calcium supplementation dose 1, 2
If inadequate response (persistent hypocalcemia or elevated PTH):
- Increase calcitriol dose gradually at 2–4 week intervals 2
- Ensure adequate calcium supplementation is being given 1
- Rule out vitamin D deficiency (25(OH)D <30 ng/mL) and supplement with cholecalciferol if needed 3
- Consider malabsorption, which may require larger doses 2
Common Pitfalls to Avoid
Do not normalize serum calcium to high-normal levels:
- Targeting high-normal calcium increases risk of hypercalciuria and nephrocalcinosis 1
- Low-normal to mid-normal calcium is the appropriate target 1
Do not use calcitriol as monotherapy without calcium:
- Always combine with calcium supplementation unless contraindicated 1
- Calcitriol alone increases hypercalciuria risk 4
Do not give calcium and calcitriol together:
- Space doses throughout the day (3 times daily for both) to optimize absorption and minimize peaks 1
Monitor for nephrocalcinosis:
- Perform renal ultrasound annually in children on chronic calcitriol therapy 1
- Keep urinary calcium excretion within normal range 1
Special Considerations for Infants
Genetic etiology is common in this age group:
- Determine underlying cause (genetic testing for CASR, PTH, GCM2, etc.) as this impacts prognosis and monitoring 1
- Conditions like APECED may be resistant to conventional therapy and require higher doses or PTH replacement 1
Growth and development are critical outcomes:
- Optimize therapy to achieve normal linear growth and bone accrual 1
- Inadequate treatment can impair growth; excessive treatment causes nephrocalcinosis 1
Liquid formulation advantages: